跳至主要内容
临床试验/NCT01979887
NCT01979887已完成不适用

Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction

Allergan0 个研究点目标入组 75 人开始时间: 2013年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Allergan
入组人数
75
主要终点
Meibum Quality Score in the Study Eye as Assessed by the Investigator Using a 4-Point Scale

研究概览

简要总结

This is an exploratory study to evaluate endpoints used to characterize participants with and without meibomian gland dysfunction (MGD) and will evaluate the correlation between signs and symptoms of MGD. No investigational drug will be administered in this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants characterized as with or without Meibomian Gland Dysfunction.

排除标准

  • Lid heating therapy, therapeutic gland expression, or meibomian gland probing within 12 months of enrollment
  • Contact lens use in the 30 days prior to enrollment
  • Lid hygiene within 48 hours prior to enrollment
  • Use of eye makeup within 8 hours of enrollment
  • Eyelash growth-stimulating products within 30 days prior to enrollment
  • Use of systemic vitamins and/or systemic supplements containing omega 3 fatty acids within 60 days of enrollment
  • Use of systemic anti-histamines within 30 days prior to enrollment.

结局指标

主要结局

Meibum Quality Score in the Study Eye as Assessed by the Investigator Using a 4-Point Scale

时间窗: Day 22

次要结局

未报告次要终点

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验